APA (7th ed.) Citation

YJ, K., Q, L., J, W., A, K., J, C., J, Z., . . . J, S. (2025). Informing health system planning for biomarker-based treatment: Statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042. The Lancet regional health. Western Pacific, 57, 101537. https://doi.org/10.1016/j.lanwpc.2025.101537

Chicago Style (17th ed.) Citation

YJ, Kang, Luo Q, Worthington J, Kelly A, Cuff J, Zalcberg J, Canfell K, and Steinberg J. "Informing Health System Planning for Biomarker-based Treatment: Statistical Prevalence Projections for Solid Cancers with Key Pan-tumour Biomarkers (dMMR, MSI, High TMB) in Australia to 2042." The Lancet Regional Health. Western Pacific 57 (2025): 101537. https://doi.org/10.1016/j.lanwpc.2025.101537.

MLA (9th ed.) Citation

YJ, Kang, et al. "Informing Health System Planning for Biomarker-based Treatment: Statistical Prevalence Projections for Solid Cancers with Key Pan-tumour Biomarkers (dMMR, MSI, High TMB) in Australia to 2042." The Lancet Regional Health. Western Pacific, vol. 57, 2025, p. 101537, https://doi.org/10.1016/j.lanwpc.2025.101537.